(Q37392125)

20 August 2017

1 reference

title

Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease (English)

1 reference

20 August 2017

0 references

J V Donadio

1

1 reference

PubMed ID

1921484

20 August 2017

language of work or name

English

0 references

publication date

1 October 1991

1 reference

20 August 2017

1 reference

20 August 2017

66

1 reference

20 August 2017

10

1 reference

20 August 2017

1018-1028

1 reference

Treatment of proteinuric idiopathic glomerulonephritides in adults: a retrospective survey

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Idiopathic membranous nephropathy: The natural history of untreated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Steroid therapy in primary glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Risk factors in idiopathic renal vasculitis and glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Membranoproliferative Glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Cardiovascular Effects of n-3 Fatty Acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Effects of dietary enrichment with eicosapentaenoic acid upon autoimmune nephritis in female NZBXNZW/F1 MICE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Background to essential fatty acids and their prostanoid derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Dietary requirements and functions of α-linolenic acid in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Control of polyunsaturated acids in tissue lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

The effect of fish oil consumption on platelet aggregation responses in washed human platelet suspensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Fatty acid composition of the plasma lipids in Greenland Eskimos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Eicosanoids and the modulation of glomerular immune injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Increased renal thromboxane production in murine lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Protective effect of polyunsaturated fatty acid supplementation in apoferritin induced murine glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Beneficial effects of polyunsaturated fatty acids in partially nephrectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Effect of dietary lipids on renal function in rats with subtotal nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Effects of dietary fish oil on renal insufficiency in rats with subtotal nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Nutritive value of marine oils. I. Menhanden oil atvarying oxidation levels, with and without antioxidants in rat diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Eicosapentaenoic acid and IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961725-X

10.1016/S0025-6196(12)61725-X

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

1921484